$BRSP Balance Sheet | Understand Stock

$BRSP

$3.72 +$0.03 (0.81%) Close

$BRSP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Cash and cash equivalents
Primary beneficiary
Total cash and cash equivalents
Restricted cash
Primary beneficiary
Total restricted cash
Loans and preferred equity held for investment
Current expected credit loss reserve
Loans and preferred equity held for investment, net
Primary beneficiary
Total loans and preferred equity held for investment, net
Real estate securities, available for sale, at fair value
Real estate, net
Primary beneficiary
Total real estate, net
Investments in unconsolidated ventures
Primary beneficiary
Total investments in unconsolidated ventures

Receivables, net
Primary beneficiary
Total receivables, net
Deferred leasing costs and intangible assets, net
Primary beneficiary
Total deferred leasing costs and intangible assets, net
Assets held for sale
Other assets
Primary beneficiary
Total other assets
Mortgage loans held in securitization trusts, at fair value
Primary beneficiary
Total mortgage loans held in securitization trusts, at fair value
Primary beneficiary
Total assets

Liabilities
Securitization bonds payable, net
Primary beneficiary
Total securitization bonds payable, net
Mortgage and other notes payable, net
Primary beneficiary
Total mortgage and other notes payable, net
Credit facilities
Primary beneficiary
Total credit facilities
Due to related party (Note 10)
Accrued and other liabilities
Primary beneficiary
Total accrued and other liabilities
Intangible liabilities, net
Primary beneficiary
Total intangible liabilities, net
Liabilities related to assets held for sale
Escrow deposits payable
Primary beneficiary
Total escrow deposits payable
Dividends payable
Mortgage obligations issued by securitization trusts, at fair value
Primary beneficiary
Total mortgage obligations issued by securitization trusts, at fair value
Primary beneficiary
Total liabilities

Equity
Stockholders’ equity
Preferred stock, $0.01 par value, 50,000,000 shares authorized, no shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Common stock, $0.01 par value per share, Class A, 950,000,000 shares authorized, 126,789,991 and 128,627,246 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders’ equity
Noncontrolling interests in investment entities
Noncontrolling interests in the Operating Partnership
Total equity

Total liabilities and equity

Comments